Validation of the nighttime symptoms score as a clinically relevant measure of allergic rhinitis

Allergy and Asthma Proceedings

Volumn 27, Issue 3, 2006, Pages 231-239

  Santanello, Nancy C ^a   DeMuro Mercon, Carla ^a   Shah, Shailen R ^b   Schenkel, Eric J ^c   Ratner, Paul H ^d   Dass, S Balachandra ^a   Norquist, Josephine M ^a   Philip, George ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Allergy and Asthma Consultants NJ/PA   (United States)

^c Valley Clinical Research Center   (United States)

^d Sylvana Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CIRCADIAN RHYTHM; FEMALE; HAY FEVER; HOSPITALIZATION; HUMAN; INSOMNIA; MALE; MIDDLE AGED; NOSE OBSTRUCTION; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; VALIDATION STUDY;

ADOLESCENT; ADULT; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL OBSTRUCTION; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 33746622142     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2006.27.2849     Document Type: Article

References (22)

1. Storms WW. Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis. J Allergy Clin Immunol 114(suppl 5):S146-S153, 2004.
2. Craig TJ, Teets S, Lehman EB, et al. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol 101:633-637, 1998.
3. Fisher L, Ghaffari G, Davies M, et al. Effects of poor sleep in allergic rhinitis. Curr Opin Allergy Clin Immunol 5:11-16, 2005.
4. Bousquet J, Van Cauwenberge P, and Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108(suppl 5):S147-S334, 2001.
5. van Adelsberg J, Philip G, LaForce CF, et al. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis. Ann Allergy Asthma Immunol 90:214-222, 2003.
6. van Adelsberg J, Philip G, Pedinoff A, et al. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week period. Allergy 58:1268-1276, 2003.
7. Nayak AS, Philip G, Lu S, et al. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol 88:592-600, 2002.
8. Philip G, Malmstrom K, Hampel FC, et al. Montelukast for treating seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy 32:1020-1028, 2002.
9. Meltzer EO, Malmstrom K, Lu S, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 105:917-922, 2000.
10. Ratner PH, Rowland WC, Arastu R, et al. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast. Ann Allergy Asthma Immunol 90:536-542, 2003.
11. Pullerits T, Praks L, Ristioja V, et al. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 109:949-955, 2002.
12. Meltzer E, Philip G, Weinstein SF, et al. Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis. Am J Rhinol 19(6):591-598, 2005.
13. Juniper EF, and Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 21:77-83, 1991.
14. Portney LG, and Watkins MP. Correlations. In Foundations of Clinical Research: Applications to Practice. Mehalik C (Ed.). Chap. 6. New York: Prentice-Hall, Inc., 491-508, 2000.
15. Cronbach LJ. Coefficient alpha and the internal structure of a test. Psychometrika 16:197-234, 1951.
16. Streiner DL. A checklist for evaluating the usefulness of rating scales. Can J Psychiatry 38:140-148, 1993.
17. Jen A, Baroody F, de Tineo M, et al. As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 105:732-738, 2000.
18. Meltzer EO, Casale TB, Nathan RA, et al. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 83311-317, 1999.
19. Juniper EF, Guyatt GH, Andersson B, et al. Comparison of powder and aerosolized budesonide in perennial rhinitis: Validation of rhinitis quality of life questionnaire. Ann Allergy 70:225-230, 1993.
20. Ellis AK, Day JH, and Lundie MJ. Impact on quality of life during an allergen challenge research trial. Ann Allergy Asthma Immunol 83:33-39, 1999.
21. Juniper EF, Rohrbaugh T, and Meltzer EO. A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. J Allergy Clin Immunol 111:484-490, 2003.
22. Juniper EF, Thompson AK, Ferrie PJ, et al. Development and validation of the Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 30:140, 2000.